½ÃÀ庸°í¼­
»óǰÄÚµå
1619305

½ÉÀå ÆäÀ̽º¸ÞÀÌÄ¿ ½ÃÀå ±Ô¸ð, Á¡À¯À², ¼ºÀå ºÐ¼®, À¯Çüº°, ÃÖÁ¾ »ç¿ëÀÚº°, Áö¿ªº° - »ê¾÷º° ¿¹Ãø(2024-2031³â)

Cardiac Pacemaker Market Size, Share, Growth Analysis, By Type (External Pacemakers, Implantable Pacemakers), By End User (Hospitals, Cardiac Clinics), By Region - Industry Forecast 2024-2031

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: SkyQuest | ÆäÀÌÁö Á¤º¸: ¿µ¹® 157 Pages | ¹è¼Û¾È³» : 3-5ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

½ÉÀå ÆäÀ̽º¸ÞÀÌÄ¿ ¼¼°è ½ÃÀå ±Ô¸ð´Â 2022³â 39¾ï 2,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú½À´Ï´Ù. ½ÃÀåÀº 2023³â 40¾ï 4,000¸¸ ´Þ·¯¿¡¼­ 2031³â 51¾ï 6,000¸¸ ´Þ·¯·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ¿¹Ãø ±â°£(2024-2031³â) µ¿¾È 3.1%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)À» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¼¼°è ½ÉÀå ÆäÀ̽º¸ÞÀÌÄ¿ ½ÃÀåÀº ½ÉÇ÷°ü ÁúȯÀÇ À¯º´·ü Áõ°¡¿Í °í·ÉÈ­·Î ÀÎÇØ Å©°Ô ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. »ýȰ½À°üÀÇ º¯È­¿Í °°Àº ¿äÀÎÀ¸·Î ÀÎÇØ ½ÉÀåÁúȯÀÇ À§ÇèÀÌ ´õ¿í Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ±â¼úÀÇ Çõ½ÅÀû ¹ßÀüÀ¸·Î ¿ø°Ý ¸ð´ÏÅ͸µ ±â´É°ú ÀÚµ¿ »ý¸®Àû Á¶Àý ±â´ÉÀ» °®Ãá ¼ÒÇü ¹«¼± ½É¹ÚÁ¶À²±â°¡ °³¹ßµÇ°í ÀÖ½À´Ï´Ù. Á¶±â Áø´Ü¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö°í ½ÅÈï±¹ ½ÃÀåÀÇ ÀÇ·á ÀÎÇÁ¶ó°¡ °³¼±µÇ°í ÀÖ´Â °Íµµ ½ÃÀå È®´ë¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¿¬±¸°³¹ß¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡¿Í ÀÇ·á±â±â Á¦Á¶¾÷ü¿Í ÀÇ·á ¼­ºñ½º Á¦°ø¾÷ü °£ÀÇ Çù·Â °ü°èµµ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù. ±×·¯³ª ³ôÀº ÀÌ½Ä ºñ¿ë°ú ¿ø°ÝÁö¿¡¼­ÀÇ Á¢±Ù¼º Á¦ÇÑÀº ½ÃÀå ¼ºÀåÀ» ÀúÇØÇÏ´Â ¿äÀÎÀ¸·Î ÀÛ¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù. Àü¹ÝÀûÀ¸·Î, Áö¼ÓÀûÀÎ ±â¼ú Çõ½Å°ú ÃÖ¼Òħ½À ¼ö¼ú·ÎÀÇ ÀüȯÀ¸·Î ÀÎÇØ ½ÃÀåÀº Å« ÆøÀÇ ¼ºÀåÀ» ÀÌ·ê °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

¸ñÂ÷

¼­·Ð

  • Á¶»ç ¸ñÀû
  • Á¶»ç ¹üÀ§
  • Á¤ÀÇ

Á¶»ç ¹æ¹ý

  • Á¤º¸ Á¶´Þ
  • 2Â÷ µ¥ÀÌÅÍ¿Í 1Â÷ µ¥ÀÌÅÍ ¹æ¹ý
  • ½ÃÀå ±Ô¸ð ¿¹Ãø
  • ½ÃÀå ÀüÁ¦Á¶°Ç°ú Á¦ÇÑ

ÁÖ¿ä ¿ä¾à

  • ¼¼°è ½ÃÀå Àü¸Á
  • °ø±Þ°ú ¼ö¿ä µ¿Ç⠺м®
  • ºÎ¹®º° ±âȸ ºÐ¼®

½ÃÀå ¿ªÇаú Àü¸Á

  • ½ÃÀå °³¿ä
  • ½ÃÀå ±Ô¸ð
  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀΰú ±âȸ
    • ¼ºÀå ¾ïÁ¦¿äÀΰú °úÁ¦
  • PorterÀÇ Five Forces ºÐ¼®

ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ®

  • Áß¿ä ¼º°ø ¿äÀÎ
  • °æÀï Á¤µµ
  • ÁÖ¿ä ÅõÀÚ ±âȸ
  • ½ÃÀå »ýŰè
  • ½ÃÀåÀÇ ¸Å·Â Áö¼ö(2023³â)
  • PESTEL ºÐ¼®
  • °Å½Ã°æÁ¦ ÁöÇ¥
  • ¹ë·ùüÀÎ ºÐ¼®
  • °¡°Ý ºÐ¼®
  • ±â¼ú Áøº¸
  • »ç·Ê ¿¬±¸
  • ¹«¿ª ºÐ¼®

½ÉÀå ÆäÀ̽º¸ÞÀÌÄ¿ ½ÃÀå ±Ô¸ð : À¯Çüº°

  • ½ÃÀå °³¿ä
  • ü¿Ü ÆäÀ̽º¸ÞÀÌÄ¿
    • ½Ì±Û è¹ö
    • µà¾ó è¹ö
  • À̽ÄÇü ÆäÀ̽º¸ÞÀÌÄ¿
    • ±âÁ¸
    • ¸®µå·¹½º

½ÉÀå ÆäÀ̽º¸ÞÀÌÄ¿ ½ÃÀå ±Ô¸ð : ÃÖÁ¾»ç¿ëÀÚº°

  • ½ÃÀå °³¿ä
  • º´¿ø
  • ½ÉÀå Ŭ¸®´Ð
  • ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)
  • ±âŸ

½ÉÀå ÆäÀ̽º¸ÞÀÌÄ¿ ½ÃÀå ±Ô¸ð : Áö¿ªº°

  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
  • À¯·´
    • µ¶ÀÏ
    • ½ºÆäÀÎ
    • ÇÁ¶û½º
    • ¿µ±¹
    • ÀÌÅ»¸®¾Æ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • Àεµ
    • ÀϺ»
    • Çѱ¹
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
    • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • GCC ±¹°¡
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

°æÀï Á¤º¸

  • ÁÖ¿ä 5°³»ç ºñ±³
  • ÁÖ¿ä ±â¾÷ÀÇ ½ÃÀå Æ÷Áö¼Å´×(2023³â)
  • ÁÖ¿ä ½ÃÀå ±â¾÷ÀÌ Ã¤ÅÃÇÑ Àü·«
  • ½ÃÀå ÃÖ±Ù µ¿Çâ
  • ±â¾÷ÀÇ ½ÃÀå Á¡À¯À² ºÐ¼®(2023³â)
  • ÁÖ¿ä ±â¾÷ °³¿ä
    • ±â¾÷ °³¿ä
    • Á¦Ç° Æ÷Æ®Æú¸®¿À ºÐ¼®
    • ºÎ¹®º° Á¡À¯À² ºÐ¼®
    • ¸ÅÃâ Àü³â´ëºñ ºñ±³(2021-2023³â)

ÁÖ¿ä ±â¾÷ °³¿ä

  • Medtronic PLC
  • Abbott Laboratories
  • Boston Scientific Corporation
  • Biotronik SE & Co. KG
  • Lepu Medical Technology Co., Ltd.
  • LivaNova PLC
  • Osypka AG
  • Oscor Inc.
  • Pacetronix
  • Medico S.R.L.
  • MicroPort Scientific Corporation
  • Shree Pacetronix Ltd.
  • ZOLL Medical Corporation
  • Asahi Kasei Corporation
  • OSYPKA Medical GmbH
  • Cardiac Science Corporation
  • EBR Systems, Inc.
  • BioTrace Medical, Inc.
  • Sorin Group(LivaNova)
  • Vitatron(Medtronic)

°á·Ð°ú Ãßõ »çÇ×

LSH 25.01.10

Global Cardiac Pacemaker Market size was valued at USD 3.92 billion in 2022 and is poised to grow from USD 4.04 billion in 2023 to USD 5.16 billion by 2031, growing at a CAGR of 3.1% during the forecast period (2024-2031).

The Global Cardiac Pacemaker Market is witnessing significant growth, driven by the rising prevalence of cardiovascular diseases and an aging population. Factors such as lifestyle changes are further escalating the risk of heart issues. Innovative advancements in technology have led to the development of smaller, wireless pacemakers featuring remote monitoring capabilities and automatic physiological adjustments. Increased awareness of early diagnosis and enhancements in healthcare infrastructure in developing regions also contribute to market expansion. Additionally, heightened investment in research and development, along with collaborations between device manufacturers and healthcare providers, is stimulating growth. However, challenges like high implantation costs and limited access in remote areas may hinder progress. Overall, the market is set for substantial growth due to ongoing innovations and a shift towards minimally invasive procedures.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cardiac Pacemaker market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cardiac Pacemaker Market Segmental Analysis

Global Cardiac Pacemaker Market is segmented by type, end user and region. Based on type, the market is segmented into external pacemakers and implantable pacemakers. Based on end user, the market is segmented into hospitals, cardiac clinics, ambulatory surgery centers and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Cardiac Pacemaker Market

One of the primary factors propelling the Global Cardiac Pacemaker Market is the rising prevalence of cardiovascular diseases. As the occurrence of heart-related issues such as arrhythmias and heart failure escalates around the world, the demand for cardiac pacemakers to effectively manage and treat these ailments intensifies. This trend is further exacerbated by lifestyle factors such as sedentary behavior, poor dietary choices, and an aging demographic, all of which collectively increase the incidence and burden of cardiovascular diseases globally. Consequently, the heightened need for innovative cardiac solutions significantly drives market growth and expansion.

Restraints in the Global Cardiac Pacemaker Market

A significant constraint within the Global Cardiac Pacemaker market is the elevated expenses linked to pacemaker implantation procedures. These advanced medical devices necessitate expertise from trained medical professionals along with specialized equipment and comprehensive post-operative care. The cumulative costs-including the pacemaker itself, surgical expenses, hospitalization, and subsequent follow-up-can be quite high, imposing a heavy financial strain on many patients. This economic hurdle limits access to essential cardiac care, especially for individuals in lower-income areas or those lacking sufficient insurance coverage, ultimately hindering the overall growth of the market.

Market Trends of the Global Cardiac Pacemaker Market

A prominent trend in the Global Cardiac Pacemaker Market is the rising adoption of remote monitoring technologies. This shift is fueled by the demand for continuous patient oversight and the urgent need for early detection of device malfunctions and abnormalities. Remote monitoring solutions allow healthcare providers to assess and track pacemaker performance in real-time, significantly improving patient care through timely interventions and minimizing the necessity for frequent hospital visits. The integration of advanced communication technologies and wireless connectivity has streamlined data transmission, enhancing patient outcomes and engagement. As a result, remote monitoring is becoming an essential feature in cardiac care strategies, shaping the future landscape of the market.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2023
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Technological Advancement
  • Case Studies
  • Trade Analysis

Global Cardiac Pacemaker Market Size by Type & CAGR (2024-2031)

  • Market Overview
  • External Pacemakers
    • Single Chamber
    • Dual Chamber
  • Implantable Pacemakers
    • Conventional
    • Leadless

Global Cardiac Pacemaker Market Size by End User & CAGR (2024-2031)

  • Market Overview
  • Hospitals
  • Cardiac Clinics
  • Ambulatory Surgery Centers
  • Others

Global Cardiac Pacemaker Market Size & CAGR (2024-2031)

  • North America (Type, End User)
    • US
    • Canada
  • Europe (Type, End User)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Type, End User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Type, End User)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Type, End User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2023
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2023
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

  • Medtronic PLC
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Abbott Laboratories
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Boston Scientific Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Biotronik SE & Co. KG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Lepu Medical Technology Co., Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • LivaNova PLC
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Osypka AG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Oscor Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Pacetronix
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medico S.R.L.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • MicroPort Scientific Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Shree Pacetronix Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • ZOLL Medical Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Asahi Kasei Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • OSYPKA Medical GmbH
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cardiac Science Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • EBR Systems, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BioTrace Medical, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sorin Group (LivaNova)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Vitatron (Medtronic)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations

ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦